Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities

1998 ◽  
Vol 27 (2) ◽  
pp. 57-71 ◽  
Author(s):  
Henk-Jan van der Woude ◽  
Johan L. Bloem ◽  
Pancras C. W. Hogendoorn
Keyword(s):  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
Preoperative Evaluation ◽  
Imaging Modalities ◽  
High Grade ◽  
Evaluation And Monitoring

Chemotherapy in the Management of Osteosarcoma and Ewing's Sarcoma

2007 ◽  
Vol 5 (4) ◽  
pp. 449-455 ◽  
Author(s):  
Scott M. Schuetze
Keyword(s):  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
Disease Patient ◽  
Bone Sarcoma ◽  
The United States ◽  
High Grade ◽  
Medical Oncologists ◽  
Bone Sarcomas ◽  
Localized Disease ◽  
Relapsed Disease

Sarcomas of bone are rare malignancies diagnosed in fewer than 3000 individuals yearly in the United States. Ewing's sarcoma and most osteosarcoma are high-grade neoplasms and account for approximately one half of bone sarcoma cases. Fewer than 20% of patients presenting with localized Ewing's sarcoma or osteosarcoma are cured with surgery alone. Current management typically involves collaboration among orthopedic oncologists, medical oncologists, musculoskeletal radiologists, sarcoma pathologists, and radiation oncologists. Modern multidisciplinary management of Ewing's sarcoma and osteosarcoma has improved the cure rate of patients with localized disease to more than 50%. Primary chemotherapy for high-grade bone sarcomas often involves intensive, multiagent regimens, and few secondary chemotherapy options are available to treat refractory or relapsed disease. Patient participation in clinical trials of novel therapies for Ewing's sarcoma and osteosarcoma should be strongly encouraged.

scholarly journals Aggressive high-grade Ewing's sarcoma of maxilla: A rare case report

2018 ◽  
Vol 22 (4) ◽  
pp. 48
Author(s):  
Hema Keswani ◽  
TL Yogesh ◽  
Akshay Shetty ◽  
Diljith Rishi
Keyword(s):  
Case Report ◽  
Rare Case ◽  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
High Grade ◽  
Rare Case Report

Ewing's Sarcoma of Bone and Soft Tissues

1989 ◽  
Vol 98 (5) ◽  
pp. 400-402 ◽  
Author(s):  
Nour Sneige ◽  
John G. Batsakis
Keyword(s):  
Soft Tissue ◽  
Soft Tissues ◽  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
Combined Modality Treatment ◽  
High Grade ◽  
Facial Bones ◽  
Grade Malignancy ◽  
High Grade Malignancy ◽  
Tissue Origin

Ewing's sarcoma is a distinctive clinical and pathologic entity that may be intraosseous or of soft-tissue origin. In the facial bones, the incidence of the sarcoma is estimated at 2.5% of all Ewing's sarcoma of bone. The soft tissues of the head and neck account for 11% of extraskeletal sites of the neoplasm. Combined modality treatment has modified its high-grade malignancy.

Extraskeletal Ewing’s sarcoma presenting as a neck mass - case report

ORL ro ◽  
2017 ◽  
Vol 2 (35) ◽  
pp. 24
Author(s):  
Daniel Mirea ◽  
Loredana Mitran ◽  
Daniela Safta ◽  
Cornelia Niţipir ◽  
Bogdan Mocanu ◽  
...  
Keyword(s):  
Case Report ◽  
Ewing’S Sarcoma ◽  
Ewing's Sarcoma ◽  
Neck Mass ◽  
Extraskeletal Ewing’S Sarcoma ◽  
Mass Case
Sign in / Sign up

Export Citation Format

Share Document